Order Article Reprints

Huang X-S, Tian R-R, Ma M-D, Luo R-H, Yang L-M, Peng G-H, Zhang M, Dong X-Q, Zheng Y-T. Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment. Pharmaceuticals. 2022; 15(3):338. https://doi.org/10.3390/ph15030338

Huang, Xu-Sheng, Ren-Rong Tian, Meng-Di Ma, Rong-Hua Luo, Liu-Meng Yang, Guang-Hui Peng, Mi Zhang, Xing-Qi Dong, and Yong-Tang Zheng. 2022. "Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment" Pharmaceuticals 15, no. 3: 338. https://doi.org/10.3390/ph15030338

Huang, X.-S., Tian, R.-R., Ma, M.-D., Luo, R.-H., Yang, L.-M., Peng, G.-H., Zhang, M., Dong, X.-Q., & Zheng, Y.-T. (2022). Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment. Pharmaceuticals, 15(3), 338. https://doi.org/10.3390/ph15030338